Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Open in API
Filings indexed 509 across all filing types
Latest filing 2017-01-09 Regulatory Filings
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Information Form and Checklist 14 pages 433.3KB
Regulatory Filings Classification · 95% confidence The document is titled 'Information Form and Checklist (ASX Listing)' and contains detailed corporate information about Lifespot Health Ltd, including incorporation details, management details, auditor details, registry details, and compliance checklists related to admission to the official list of ASX Limited. It includes references to the ASX Listing Rules, Offer Document, and various compliance confirmations. The document is clearly an application and supporting information for listing on the ASX, not a financial report, earnings release, or management discussion. It is a regulatory filing related to the listing process and compliance with listing requirements. The document is lengthy (15,000 characters) and contains detailed information but does not present financial statements or earnings data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2017-01-09 English
Terms and Conditions - Options 2 pages 193.0KB
Capital/Financing Update Classification · 95% confidence The document details the terms and conditions for the issue of options by Lifespot Health Ltd, including exercise price, exercise period, transferability, and adjustments related to capital reorganizations and bonus issues. It is a formal announcement about the issuance of options, which relates to changes in the company's capital structure. The document length is 3649 characters, which is relatively short and does not contain financial statements or performance data. It is not an annual or interim report, nor a management discussion or earnings release. It is not a proxy, voting result, or governance document. The content fits best under Capital/Financing Update (CAP) as it announces the issuance of options, a financing-related activity affecting capital structure.
2017-01-09 English
BodyTel GmbH - 31 December 2014 Audit Report 14 pages 276.8KB
Audit Report / Information Classification · 100% confidence The document is titled 'Audit Report' and contains detailed financial statements including balance sheet, income statement, notes to the financial statements, statement of changes in equity, cash flow statement, and an auditor's report. The financial statements are for the shortened financial year ending December 31, 2014. The auditor's report is included as part of the document, providing an opinion on the annual financial statements prepared according to German commercial law (HGB). The document is comprehensive, over 15,000 characters, and contains substantive financial data and analysis. It is not merely an announcement or certification but the actual audited financial statements and audit report. Therefore, this document fits the category of an Audit Report / Information (AR). FY 2014
2017-01-09 English
BodyTel GmbH - 31 December 2015 Audit Report 14 pages 349.7KB
Audit Report / Information Classification · 100% confidence The document is titled 'Audit Report' and contains detailed financial statements including balance sheet, income statement, notes to the financial statements, statement of changes in equity, cash flow statement, and an auditor's report. The audit report is directed to BodyTel GmbH and includes the auditor's opinion on the annual financial statements for the fiscal year ending December 31, 2015. The document is comprehensive and includes the auditor's assessment and confirmation that the financial statements comply with legal requirements and give a true and fair view. This is a standalone audit report with detailed financial data and audit opinion, not a full annual report or just an announcement. Therefore, the document fits the category of Audit Report / Information (AR). FY 2015
2017-01-09 English
BodyTel GmbH - 30 June 2016 Half Year Report 21 pages 1.5MB
Audit Report / Information Classification · 95% confidence The document is a certified translation of an audit review report for the condensed interim financial statements of BodyTel GmbH for the period ending 30 June 2016. It includes balance sheets, income statements, and a detailed audit review report by auditors. The document contains actual financial data and an auditor's review, not just an announcement or certification. The presence of an audit review report on interim financial statements aligns with the category of Audit Report / Information (AR), as it is a standalone audit review and not a full annual report or interim report itself. The document is not a full Annual Report (10-K) or Interim Report (IR) because it is specifically an audit review report. Therefore, the correct classification is AR with high confidence. H1 2016
2017-01-09 English
Lifespot AG - 31 December 2013 Audit Report 15 pages 325.7KB
Audit Report / Information Classification · 100% confidence The document is titled 'Audit Report' and contains detailed financial statements including balance sheet, income statement, notes to the financial statements, statement of changes in equity, and cash flow statement for the shortened financial year ending December 31, 2013. It also includes an auditor's report with an opinion on the annual financial statements prepared according to German commercial law (HGB). The document is comprehensive and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it is a standalone audit report rather than a full annual report or other filing type. FY 2013
2017-01-09 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.